Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W Brunner

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Schweizerische Medizinische Wochenschrift|April 17, 1982
[Prevention of cytostatic-related hair loss by hypothermia of a hairy scalp using a cooling cap]A Goldhirsch, J Kiser, R Joss, et al.
Schweizerische Medizinische Wochenschrift|May 16, 1987
[Hodgkin's disease in a Swiss family]M F Fey, R A Joss, W J Pichler, et al.
Cancer|July 1, 1988
Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapyA Goldhirsch, R Greiner, E Dreher, et al.
Cancer|August 1, 1994
Present and future projects of the International Breast Cancer Study GroupA Goldhirsch, R D Gelber, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1993
Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled studyK S Buser, R A Joss, D Piquet, et al.
The New England Journal of Medicine|December 3, 1987
Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancerS D Williams, D M Stablein, L H Einhorn, et al.
Medical and Pediatric Oncology|January 1, 1979
A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemiaP H Wiernik, O J Glidewell, H C Hoagland, et al.
Cancer Chemotherapy Reports|April 1, 1971
Failure of hydroxyurea (NSC-32065) and prednisone (NSC-10023) in the treatment of acute myelocytic leukemiaF Rosner, O Glidewell, R R Ellison, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Schweizerische Medizinische Wochenschrift|April 17, 1982
[Prevention of cytostatic-related hair loss by hypothermia of a hairy scalp using a cooling cap]A Goldhirsch, J Kiser, R Joss, et al.
Schweizerische Medizinische Wochenschrift|May 16, 1987
[Hodgkin's disease in a Swiss family]M F Fey, R A Joss, W J Pichler, et al.
Cancer|July 1, 1988
Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapyA Goldhirsch, R Greiner, E Dreher, et al.
Cancer|August 1, 1994
Present and future projects of the International Breast Cancer Study GroupA Goldhirsch, R D Gelber, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1993
Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled studyK S Buser, R A Joss, D Piquet, et al.
The New England Journal of Medicine|December 3, 1987
Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancerS D Williams, D M Stablein, L H Einhorn, et al.
Medical and Pediatric Oncology|January 1, 1979
A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemiaP H Wiernik, O J Glidewell, H C Hoagland, et al.
Cancer Chemotherapy Reports|April 1, 1971
Failure of hydroxyurea (NSC-32065) and prednisone (NSC-10023) in the treatment of acute myelocytic leukemiaF Rosner, O Glidewell, R R Ellison, et al.
Pageof 15